| Name | Title | Contact Details |
|---|
In a time when humanity needs to rethink the future to sustain life on this planet, we consider responsible business a necessary game changer. That is why we are a company that offers 100% organic cotton products for customers who seek delicious, sustainable goods of premium quality. We want our products to last long enough to be passed on. We create them to be enjoyed and used. And we insist on developing a new, sustainable standard of designed goods. #design #functionality #longlasting #newstandard #BCorp #GOTS #organic #feelgood
Kersia Group is a global leader in biosecurity and food safety, focused on ensuring the safety of food production, processing, distribution, and consumption. The company aims to create a food-safe world by providing innovative and sustainable solutions that prevent diseases and contamination throughout the food supply chain. Kersia offers a variety of services to enhance food safety and operational performance. These include plant sanitation assessments, inventory usage management, annual cleaning validation, routine plant visits, and sanitation audits. The company collaborates with clients to optimize sanitation programs, ensuring high hygiene standards and compliance with regulatory requirements. With a significant presence in the United States and headquartered in France, Kersia USA specifically addresses food safety challenges in the meat and poultry processing sectors. The company is dedicated to supporting various industries, including dairy and healthcare, by delivering tailored solutions that enhance operational efficiency.
We outfit youth sports teams with customized gear – on time for game time!
2023 Earthshot Prize Finalist on a mission to protect the planet from the cost of clothing. At Circ, weve created a technology system that returns clothes to the raw materials from which they were made. Again and again. Brand partners like Patagonia, Marubeni, and Fashion For Good are joining us in our goal of turning wasteful fashion lines into renewable fashion circles. By 2030, we expect to have recycled 10 billion garments, represent 10% of the global apparel market, and to have saved more than 100 million trees. As our ecology and economy grow evermore entwined, it is clear to us that the world already has all the clothing it needs to create all the clothing it will ever need. Join us in threading together the future of circular fashion and eliminating our collective fashion footprint.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.